Bladder Cancer Clinical Trials

If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors

Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer

Quality of Life in Patients With Bladder Cancer

Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer

Screening for Bladder Cancer

Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)

Detection of Bladder Tumors After 30 Min Instillation of Hexvix

Biomarker Discovery and Application in Bladder Cancer

Dose Dense MVAC for Muscle Invasive Bladder Cancer

Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer

Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer

A Study for Treatment of Superficial Bladder Cancer Using OGX-427

Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer

Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery

Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer

Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery

Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

Multimodal Rehabilitation Program to Bladder Cancer Patients (MRPBC)

Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer

Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

Bladder Cancer Imaging Study-OCT Imaging to Stage Bladder Tumors

Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer

Genetic Susceptibility to Bladder Cancer

Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer

Evaluation of Non-Invasive Assay(s) for the Detection of Bladder Cancer

Radiation Therapy and Cisplatin in Treating Patients With Stage I Bladder Cancer

Cone Beam Computed Tomography (CT) Bladder

Molecular Analysis Of Bladder Cancer

Bladder Cancer News

Adding Chemo to Radiotherapy for MIBC Improves Outcomes

Bladder Cancer Diagnosis Encourages Smokers to Quit

Neoadjuvant Chemotherapy Urged for Rare Type of Bladder Cancer

Current Poll

Has a radiologist ever challenged one of your orders for an imaging procedure?

Click here to take the poll

Latest CME Article

Renal & Urology News includes a CME article in every print issue, which will also be available online.

View the latest installment:

Managing Bone Disease in  Kidney Transplant Recipients

Your Practice

The move from ICD-9-CM to ICD-10 is enough to strike fear into the hearts of physicians and staff alike. Making the leap from 14,000 codes to almost 69,000, topped with the huge cost to make that change, is understandably daunting.

Read more on
Coping with ICD-10

Have any practice management topics that you'd like us to cover?
Let us know.